BiotechTube
Home/Endogena Therapeutics/Matthias Steger
MS

Matthias Steger

Chief Executive Officer

Endogena Therapeutics

Therapeutic Areas

OphthalmologyPulmonologyRegenerative Medicine

Endogena Therapeutics Pipeline

DrugIndicationPhase
EA-2353Retinitis PigmentosaPhase I/IIa